Burning Rock Dx | Your Reliable Diagnostic Partner

Products

Solid Tumor Testing Minimal Residual Disease Testing Hematologic Malignancies Testing RUO/IUO: Multi-omics Detection Early Cancer Detection
Services

Pharma Biomarker & CDx Services International Diagnostics Division Sequencing Services Early Cancer Detection Services

中文 EN

Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant non-small cell lung cancer (NEOTIDE/CTONG2104): phase II trial and correlative genomic analysis in China

Release date：June 16, 2026

Announcer：Burning Rock

Previous: KYNU in macrophages contributes to the unique immune feature of LUAD via integrating single-cell and bulk RNA sequencing data: an exploratory analysis

Recommended News

June 16, 2026

KYNU in macrophages contributes to the unique immune feature of LUAD via integrating single-cell and bulk RNA sequencing data: an exploratory analysis

June 16, 2026

Simplified perioperative serplulimab and chemotherapy for resectable squamous NSCLC: a phase II trial with biomarker analysis

June 16, 2026

A Patient With Novel PPP1CB-ALK Fusion Advanced NSCLC Achieved Long Survival From Alectinib: A Case Report

June 16, 2026

A CREM-ITGA2B-MAPK axis drives proliferation and invasiveness in gastric cancer: insights from single-cell analysis

Contact Our Experts

We would like to collect certain personal information about you through cookies and similar technologies in order to personalize the site for you, improve the performance of the site, and support our marketing efforts. By clicking “Accept All”, you confirm that we have your consent to collect and process your personal information in accordance with our Privacy Policy, which may include online targeted and social media advertising in some instances. You can by clicking “Reject All”, you can reject all cookies except for Strictly Necessary Cookies."